Literature DB >> 4351970

Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody.

F A Ennis.   

Abstract

Sensitized mouse spleen cells decrease the spread of herpes simplex virus infection in cell culture lines derived from human and murine tissues. These washed, sensitized cells act alone and additively in combination with antibody to diminish the ability of single virus-infected cells to spread infection to contiguous cells. This control of infection is not species specific, unlike interferon, and appears to be distinct from the effect of antibody. Lymphotoxin was not detected in this lymphocyte-mediated response. This control of herpes simplex virus infection in vitro by sensitized lymphoid cells is immunologically specific; spleen cells from donor animals immunized with a heterotypic virus do not cause herpesvirus plaque size reduction. The ratio of spleen cells from immunized animals to target monolayer cells needed to produce this effect is > 4:1. Plaque size reduction of herpes simplex virus by spleen cells requires intact, immune, non-glass-adhering lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4351970      PMCID: PMC422780          DOI: 10.1128/iai.7.6.898-904.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  GENETIC STUDIES OF INFLUENZA VIRUSES. II. PLAQUE FORMATION BY INFLUENZA VIRUSES IN A CLONE OF A VARIANT HUMAN HETEROPLOID CELL LINE.

Authors:  A SUGIURA; E D KILBOURNE
Journal:  Virology       Date:  1965-07       Impact factor: 3.616

2.  Microepidemiology of poliomyelitis and herpes-B infections: spread of the viruses within tissue cultures.

Authors:  F L BLACK; J L MELNICK
Journal:  J Immunol       Date:  1955-03       Impact factor: 5.422

3.  Modern measles.

Authors:  F L BABBOTT; J E GORDON
Journal:  Am J Med Sci       Date:  1954-09       Impact factor: 2.378

4.  Surface antigen produced by herpes simplex virus (HSV).

Authors:  M Ito; A L Barron
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

5.  Selective effects of anti-macrophage serum, silica and anti-lymphocyte serum on pathogenesis of herpes virus infection of young adult mice.

Authors:  B Zisman; M S Hirsch; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

6.  Transfer of interferon-producing macrophages: new approach to viral chemotherapy.

Authors:  L A Glasgow
Journal:  Science       Date:  1970-11-20       Impact factor: 47.728

7.  Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes.

Authors:  J A Green; S R Cooperband; J A Rutstein; S Kibrick
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

8.  Tissue injury in lymphocytic choriomeningitis viral infection: virus-induced immunologically specific release of a cytotoxic factor from immune lymphoid cells.

Authors:  M B Oldstone; F J Dixon
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

9.  Immune specific induction of interferon production in cultures of human blood lymphocytes.

Authors:  J A Green; S R Cooperband; S Kibrick
Journal:  Science       Date:  1969-06-20       Impact factor: 47.728

10.  Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci.

Authors:  R V Blanden
Journal:  J Exp Med       Date:  1971-05-01       Impact factor: 14.307

  10 in total
  18 in total

1.  In vitro acquisition of resistance against herpes simplex virus by permissive murine macrophages.

Authors:  K K Sethi; H Brandis
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.

Authors:  J E Oakes
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

3.  Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.

Authors:  Y H Thong; M M Vincent; S A Hensen; D A Fuccillo; M Rola-Pleszczynski; J A Bellanti
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  Herpetic keratitis in athymic (nude) mice.

Authors:  J F Metcalf; D S Hamilton; R W Reichert
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

5.  Plaque size reduction as a measure of viral cell-mediated immunity.

Authors:  R L Simmons; Y Centifanto; H E Kaufman
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

6.  Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.

Authors:  F Shimizu; K Hanaumi; Y Shimizu; K Kumagai
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

7.  Proliferative and interferon responses by peripheral blood mononuclear cells after bone marrow transplantation in humans.

Authors:  M J Levin; R Parkman; M N Oxman; J M Rappeport; M Simpson; P L Leary
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

8.  Suppression of in vitro growth of virulent and avirulent herpes simplex viruses by cell-mediated immune mechanisms, antibody, and interferon.

Authors:  F Shimizu; J Satoh; M Tada; K Kumagai
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

9.  Cell-mediated immunity in mice with primary, secondary and latent herpes simplex virus infection.

Authors:  J M Darville; W A Blyth
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

10.  Role of macrophages in hepatitis induced by Herpes simplex virus types 1 and 2 in mice.

Authors:  S Mogensen
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.